REPORT ID 3342

United States Hemostat Powders Market Report 2017

Publish Date
13-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the United States Hemostat Powders market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Hemostat Powders in these regions, from 2012 to 2022 (forecast).

United States Hemostat Powders market competition by top manufacturers/players, with Hemostat Powders sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Ethicon
    C. R. Bard
    Gelita Medical
    Equimedical
    Biocer
    Celox
    Hemostasis
    MBP
    Medira
    Hemotec Medical
    Starch Medical
    Success Pharmaceutical
    Changsha Hairun

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Microfibrillar Collagen
    Chitosan
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Surgical Wound Care
    General Wound Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Hemostat Powders Market Report 2017
1 Hemostat Powders Overview
    1.1 Product Overview and Scope of Hemostat Powders
    1.2 Classification of Hemostat Powders by Product Category
        1.2.1 United States Hemostat Powders Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Hemostat Powders Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Microfibrillar Collagen
        1.2.4 Chitosan
        1.2.5 Other
    1.3 United States Hemostat Powders Market by Application/End Users
        1.3.1 United States Hemostat Powders Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Surgical Wound Care
        1.3.3 General Wound Care
    1.4 United States Hemostat Powders Market by Region
        1.4.1 United States Hemostat Powders Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Hemostat Powders Status and Prospect (2012-2022)
        1.4.3 Southwest Hemostat Powders Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Hemostat Powders Status and Prospect (2012-2022)
        1.4.5 New England Hemostat Powders Status and Prospect (2012-2022)
        1.4.6 The South Hemostat Powders Status and Prospect (2012-2022)
        1.4.7 The Midwest Hemostat Powders Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Hemostat Powders (2012-2022)
        1.5.1 United States Hemostat Powders Sales and Growth Rate (2012-2022)
        1.5.2 United States Hemostat Powders Revenue and Growth Rate (2012-2022)

2 United States Hemostat Powders Market Competition by Players/Suppliers
    2.1 United States Hemostat Powders Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Hemostat Powders Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Hemostat Powders Average Price by Players/Suppliers (2012-2017)
    2.4 United States Hemostat Powders Market Competitive Situation and Trends
        2.4.1 United States Hemostat Powders Market Concentration Rate
        2.4.2 United States Hemostat Powders Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Hemostat Powders Manufacturing Base Distribution, Sales Area, Product Type

3 United States Hemostat Powders Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Hemostat Powders Sales and Market Share by Region (2012-2017)
    3.2 United States Hemostat Powders Revenue and Market Share by Region (2012-2017)
    3.3 United States Hemostat Powders Price by Region (2012-2017)

4 United States Hemostat Powders Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Hemostat Powders Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Hemostat Powders Revenue and Market Share by Type (2012-2017)
    4.3 United States Hemostat Powders Price by Type (2012-2017)
    4.4 United States Hemostat Powders Sales Growth Rate by Type (2012-2017)

5 United States Hemostat Powders Sales (Volume) by Application (2012-2017)
    5.1 United States Hemostat Powders Sales and Market Share by Application (2012-2017)
    5.2 United States Hemostat Powders Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Hemostat Powders Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Hemostat Powders Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Ethicon
        6.2.2 Hemostat Powders Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Ethicon Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 C. R. Bard
        6.3.2 Hemostat Powders Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 C. R. Bard Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Gelita Medical
        6.4.2 Hemostat Powders Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Gelita Medical Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Equimedical
        6.5.2 Hemostat Powders Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Equimedical Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Biocer
        6.6.2 Hemostat Powders Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Biocer Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Celox
        6.7.2 Hemostat Powders Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Celox Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Hemostasis
        6.8.2 Hemostat Powders Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Hemostasis Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 MBP
        6.9.2 Hemostat Powders Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 MBP Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Medira
        6.10.2 Hemostat Powders Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Medira Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Hemotec Medical
    6.12 Starch Medical
    6.13 Success Pharmaceutical
    6.14 Changsha Hairun

7 Hemostat Powders Manufacturing Cost Analysis
    7.1 Hemostat Powders Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Hemostat Powders

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Hemostat Powders Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Hemostat Powders Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Hemostat Powders Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Hemostat Powders Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Hemostat Powders Sales Volume Forecast by Type (2017-2022)
    11.3 United States Hemostat Powders Sales Volume Forecast by Application (2017-2022)
    11.4 United States Hemostat Powders Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer